Fatih Gürler

About Fatih Gürler

Fatih Gürler, With an exceptional h-index of 4 and a recent h-index of 4 (since 2020), a distinguished researcher at Gazi Üniversitesi, specializes in the field of Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

The relationship between clinical and pathological findings and FDG-PET uptake in metastatic colorectal cancers.

Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms

Tam Kan Sayımı Parametreleri ile İleri Evre Mide Kanseri Olan Hastaların Prognozunu Tahmin Edilebilir Mi?

Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study

The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.

Yumuşak Doku Sarkomlarında Neoadjuvan Sistemik Tedavi Yaklaşımları

Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy

YUMUŞAK DOKU SARKOMLARINDA NEOADJUVAN SİSTEMİK TEDAVİ YAKLAŞIMLARI

Fatih Gürler Information

University

Position

Tıp Fakültesi Tıbbi Onkoloji BD

Citations(all)

84

Citations(since 2020)

84

Cited By

19

hIndex(all)

4

hIndex(since 2020)

4

i10Index(all)

3

i10Index(since 2020)

3

Email

University Profile Page

Google Scholar

Fatih Gürler Skills & Research Interests

Oncology

Top articles of Fatih Gürler

The relationship between clinical and pathological findings and FDG-PET uptake in metastatic colorectal cancers.

Indian Journal of Cancer

2024/3/1

Retrospective Analyses of PD-L1, LAG-3, TIM-3, OX40L Expressions and MSI Status in Gastroenteropancreatic Neuroendocrine Neoplasms

Cancer investigation

2024/2/7

Fatih Gürler
Fatih Gürler

H-Index: 2

Tam Kan Sayımı Parametreleri ile İleri Evre Mide Kanseri Olan Hastaların Prognozunu Tahmin Edilebilir Mi?

Turkish Journal of Clinics and Laboratory

2023/6/6

Fatih Gürler
Fatih Gürler

H-Index: 2

Clinicopathological Features and First-Line Treatment Outcomes of Geriatric Patients With Extensive-Stage Small Cell Lung Cancer: A Multicenter Study

Cureus

2023/3/2

The relationship between hemoglobin-RDW ratio and clinical outcomes in patients with advanced pancreas cancer.

European Review for Medical & Pharmacological Sciences

2023/3/1

Yumuşak Doku Sarkomlarında Neoadjuvan Sistemik Tedavi Yaklaşımları

Turkiye Klinikleri Medical Oncology-Special Topics

2023

Fatih Gürler
Fatih Gürler

H-Index: 2

Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy

Journal of cancer research and therapeutics

2023/1/1

Fatih Gürler
Fatih Gürler

H-Index: 2

YUMUŞAK DOKU SARKOMLARINDA NEOADJUVAN SİSTEMİK TEDAVİ YAKLAŞIMLARI

2023

Real-World Outcomes of Second-Line Treatment in Sensitive Relapsed Small-Cell Lung Cancer: A Multicenter Retrospective Cohort Study

Eurasian Journal of Medical Investigation

2023

Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real …

Turk Onkoloji Dergisi

2023

Murat Gültekin
Murat Gültekin

H-Index: 8

Fatih Gürler
Fatih Gürler

H-Index: 2

Current status of biosimilars in Turkey: a survey among medical oncologists

Journal of Oncology Pharmacy Practice

2022/10

Fatih Gürler
Fatih Gürler

H-Index: 2

Volkan Aslan
Volkan Aslan

H-Index: 2

EP08. 01-024 Multicenter Real Life Clinical Outcomes of PDL-1 Tested Patients with Non Small Cell Lung Cancer (NSCLC) in Turkey

Journal of Thoracic Oncology

2022/9/1

A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

Journal of Gastrointestinal Cancer

2022/9

Fatih Gürler
Fatih Gürler

H-Index: 2

Sinonasal SMARCB1 (INI1) deficient carcinoma with yolk sac tumor differentiation: a case report and treatment options

2022/6

Fatih Gürler
Fatih Gürler

H-Index: 2

Retrospective Comparison of Chemotherapy Plus Anti-HER2 Therapies at First-line Treatment in Patients with Metastatic Gastric Adenocarcinoma

Dicle Tıp Dergisi

2022/2/9

Türkiye'de ve Dünyada Klinik Araştırmaların Durumu

Turkiye Klinikleri Medical Oncology-Special Topics

2022

Fatih Gürler
Fatih Gürler

H-Index: 2

Prognostic factors of perioperative FLOT regimen in operable gastric and

2022

Clinicopathological Features and Clinical Outcomes of Metastatic Adenocarcinoma of Unknown Primary: A Single Center Experience

Journal of oncological sciences

2022

Fatih Gürler
Fatih Gürler

H-Index: 2

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma

Turkish Journal of Medical Sciences

2022

Fatih Gürler
Fatih Gürler

H-Index: 2

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment

Anti-cancer drugs

2022/1/1

Fatih Gürler
Fatih Gürler

H-Index: 2

Fatih Yildiz
Fatih Yildiz

H-Index: 21

See List of Professors in Fatih Gürler University(Gazi Üniversitesi)